Capital Investment Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329K | Sell |
38,865
-1,000
| -3% | -$8.47K | 0.01% | 538 |
|
|
2025
Q1 | $321K | Hold |
39,865
| – | – | 0.01% | 531 |
|
|
2024
Q4 | $358K | Hold |
39,865
| – | – | 0.01% | 481 |
|
|
2024
Q3 | $292K | Hold |
39,865
| – | – | 0.01% | 520 |
|
|
2024
Q2 | $228K | Hold |
39,865
| – | – | 0.01% | 558 |
|
|
2024
Q1 | $200K | Sell |
39,865
-725
| -2% | -$3.63K | ﹤0.01% | 585 |
|
|
2023
Q4 | $365K | Hold |
40,590
| – | – | 0.01% | 439 |
|
|
2023
Q3 | $315K | Hold |
40,590
| – | – | 0.01% | 437 |
|
|
2023
Q2 | $393K | Buy |
40,590
+225
| +0.6% | +$2.18K | 0.01% | 378 |
|
|
2023
Q1 | $442K | Hold |
40,365
| – | – | 0.01% | 368 |
|
|
2022
Q4 | $174K | Buy |
40,365
+10,000
| +33% | +$43.1K | 0.01% | 546 |
|
|
2022
Q3 | $228K | Buy |
30,365
+800
| +3% | +$6.01K | 0.01% | 476 |
|
|
2022
Q2 | $297K | Buy |
29,565
+725
| +3% | +$7.28K | 0.01% | 429 |
|
|
2022
Q1 | $357K | Buy |
28,840
+13,840
| +92% | +$171K | 0.01% | 419 |
|
|
2021
Q4 | $343K | Buy |
15,000
+2,000
| +15% | +$45.7K | 0.01% | 429 |
|
|
2021
Q3 | $288K | Buy |
13,000
+3,000
| +30% | +$66.5K | 0.01% | 462 |
|
|
2021
Q2 | $130K | Buy |
+10,000
| New | +$130K | ﹤0.01% | 554 |
|